Current aspects for the treatment of axial spondyloarthritis
Int J Rheum Dis
.
2023 Jan;26(1):5-7.
doi: 10.1111/1756-185X.14473.
Authors
Chiao-Hsin Ku
1
,
Yung-Heng Lee
2
3
4
5
,
James Cheng-Chung Wei
6
7
8
,
Jürgen Braun
9
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
3
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
4
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
5
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
6
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
7
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
8
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
9
Rheumazentrum Ruhrgebiet, Herne, Germany and Ruhr-University Bochum, Bochum, Germany.
PMID:
36591903
DOI:
10.1111/1756-185X.14473
No abstract available
Publication types
Editorial
Kommentar
MeSH terms
Axial Spondyloarthritis*
Humans
Spondylarthritis* / diagnosis
Spondylarthritis* / drug therapy
Spondylitis, Ankylosing*